Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE)

NCT: NCT04655963 · ACTIVE_NOT_RECRUITING

NCT IDNCT04655963
StatusACTIVE_NOT_RECRUITING
Start Date2021-01-14
Completion2026-05-15

Brief Summary

Few treatments are available for post-stroke rehabilitation. The current study aims to develop a novel, short-term, high-dose repetitive transcranial magnetic stimulation (rTMS) based intervention to improve post-stroke cognitive problems. This study will test the safety as well as changes in cognitive function and brain activation with the administration of an accelerated rTMS protocol in chronic stroke.

Frequently Asked Questions

What is Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE)?

Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE) is a clinical trial registered under NCT04655963. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04655963?

The current status of NCT04655963 (Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE)) is: ACTIVE_NOT_RECRUITING.

When did Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE) start?

Brain Stimulation for Improving Cognition in Chronic Stroke (NEPTUNE) started on 2021-01-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑